Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Noble Acquires Property with Significant Uranium, Rare Earth, Phosphorus & Silver Mineralization (click to learn more)
V.AFM: Record Fy2024 & Q4 ‘24 Tin Production Fy2025 Production Guidance Exploration Success (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Aditxt Inc
ADTX
Healthcare
Biotechnology
Aditxt, Inc. is a biotech company focused on discovering, developing, and deploying health innovations. It develops and commercializes technologies with a focus on monitoring and modulating the immune system. Its portfolio includes Adimune, Inc., developing a new class of therapeutics designed to retrain the immune system to address organ rejection, autoimmunity, and allergies; Adivir, Inc...
., focused on identifying, developing, and commercializing new ways to treat infectious diseases, and Pearsanta, Inc., offering personalized lab testing, backed by CLIA-certified and CAP-accredited monitoring center. Adimune, Inc's immune modulation product candidate, ADI-100, is based on the Apoptotic DNA Immunotherapy platform technology, utilizes a novel approach that mimics the way bodies naturally induce tolerance to own tissues. It also offers electroencephalography (EEG) brain monitoring technologies and devices, including NeuroCap and NeuroEEG for telehealth and tele-neurology applications.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NDAQ:ADTX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
Next
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Dec 07, 2023 11:02am
ADTX ...got to $4.10 then backed off
Ho hum......wait fot the pump and volume to increase Not today tho
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Dec 07, 2023 10:58am
ADTX...... Wait for the fireworks...u ain't seen nothin yet
JMHO
Freegold Extends Mineralization Intersecting 1.88 g/t Au over 54.2m and 1.58 g/t Au over 60m
posted Jan 18, 2025 9:00am by
Freegold Ventures Limited
-
|
Results from Golden Summit in Alaska includes higher grade at depth and to the west. Hole GS2411:157 g/t Au over 3 metres from 299 metres, 1.88 g/t Au over 54.2 metres starting at 499.8 metres, and 1.58 g/t Au over 60 metres from 743 metres. Hole GS2147 showed higher grade within the SSW trend with 1.25 g/t Au over 56.5 metres from 24 metres and 196.5 g/t Au over 1.7 metres from 298.5 metres ...read more
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Dec 07, 2023 10:52am
ADTX....gettiing some low volume love & price action
Chit will hit the fan if sh price breaks $4.10
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Dec 04, 2023 12:13pm
ADTX...if it looks like a slimey slug.....
it is !!!!!!!!!!!!!!!!!
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Nov 30, 2023 8:33am
ADTX....early a.m runner on no news
On watch
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Apr 21, 2023 9:30am
ADTX...... This has got to be the "Slimiest" deal going
Do some research.....read every word printed.....time it with the share price and volume.....you will see what I mean. What pile !!!!!!!!!!!!!!!
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Jan 03, 2023 3:40pm
ADTX .... Scalped !
What a day !!!!
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 21, 2022 9:02am
New Press Release - Aditxt's (Nasdaq: ADTX) Adimune(TM) Program Has Initiated the Manufacturing Process of Immunotherapeutic Drug Candidate, ADI(TM)-100 in Preparation for Planned Psoriasis First-in-Human Trials
Aditxt, Inc. (Nasdaq: ADTX) (“Aditxt” or the “Company”), a biotech innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announces that its program Adimune™ has initiated the GMP manufacturing of drug candidate ADI™-100...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 12, 2022 9:12am
New Press Release - Aditxt, Inc. (Nasdaq: ADTX) Announces Development and Publication of a Mathematical Model for Predicting Longevity and Variations of Immune Response to Immunization to SARS-CoV-2 Infection
Results from the study evaluating AditxtScore™ for neutralizing antibodies (“NAb”) were published in the Journal of Theoretical Biology Aditxt, Inc. (Nasdaq: ADTX) (“Aditxt” or the “Company”), a biotech innovation company developing and commercializing technologies with a focus on monitoring and...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 07, 2022 9:00am
New Press Release - FedEx Features AditxtScore(TM) Immune Monitoring Center and its Service in Richmond, VA, Highlighting the Importance of Quantifying Immune Health
Aditxt, Inc.’s (NASDAQ: ADTX) (“Aditxt”, or the “Company”) AditxtScore™ is featured by FedEx in a video presentation that showcases the various ways in which both companies are playing critical roles in a challenging environment that includes the nation’s response to COVID-19. In the clip, the...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Sep 29, 2022 9:12am
New Press Release - Aditxt, Inc. (NASDAQ: ADTX) Announces That it Has Regained Compliance with Nasdaq Listing Requirements
Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt” or the “Company”), a biotech innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announces it has received confirmation from The Nasdaq Stock Market LLC Hearing Panel (“Nasdaq...
read article.
(0)
•••
PressRelease
X
Post by
PressRelease
on Sep 27, 2022 9:01am
New Press Release - Aditxt Inc. (Nasdaq: ADTX) Provides Corporate Highlights Post Reverse Stock Split and Closing of $20M Public Offering
Aditxt, Inc. (Nasdaq: ADTX) (“Aditxt” or the “Company”), a biotech innovation company developing and commercializing technologies focused on monitoring and modulating the immune system, today provides shareholders with a corporate update following the completion of a reverse stock split and...
read article.
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 26, 2022 2:20pm
ADTX...... I was mostly right except.....
There was 1 last pop in this pig..... c what happens now....near L.O.D now
(69)
•••
Iseneschal
X
Comment by
Iseneschal
on Sep 26, 2022 11:40am
RE:ADTX ..... I firmly believe that this is done for the day
It was done when it broke the $3.16 ; )
(69)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 26, 2022 11:39am
ADTX ..... I firmly believe that this is done for the day
A break of $3.09 and it 's all over but the crying JMHO
Prev
1
2
3
4
5
6
7
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Tribe Announces Preliminary Q4-2024 Results, Achieving Positive Adjusted EBITDA and Increased Revenue Run-Rate
Exploring sensor-based ore sorting, a technology using X-ray analysis and electromagnetic induction
Have you held units of a TD mutual fund, other than through a discount broker? Learn more.